Overview
- 194 inspections across 166 sites are on record.
- 235 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-01-17.
At a glance
Inspections
194
Sites
166
Observations
235
Career since
Sep 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Simcere Pharmaceutical Co., Ltd. | 17 Jan 2020 | Human Drugs | |
| Yiling Pharmaceutical Ltd | 21 Nov 2019 | Human Drugs | On file |
| CSPC Ouyi Pharmaceutical Co., Ltd. | 15 Nov 2019 | Human Drugs | |
| Changzhou Qianhong Biopharma Co., Ltd. | 23 Oct 2019 | Human Drugs | |
| Changzhou Pharmaceutical Factory | 18 Oct 2019 | Human Drugs | On file |
Sites inspected
Simcere Pharmaceutical Co., Ltd.Nanjing, China1 insp.
Yiling Pharmaceutical LtdShijiazhuang, China1 insp.
CSPC Ouyi Pharmaceutical Co., Ltd.Shijiazhuang, China1 insp.
Changzhou Qianhong Biopharma Co., Ltd.Changzhou, China1 insp.
Changzhou Pharmaceutical FactoryChangzhou, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Nicholas L Paulin14 shared
Matt D Suedkamp12 shared
Peter E Baker9 shared
Elizabeth L Edwards4 shared
Anna M Brannen4 shared
April E Mcdermitt4 shared
Thomas C Woods4 shared
Samuel A Hamblin4 shared
Cynthia T Cain4 shared
Michael P Sheehan3 shared
Full investigator report
Get the verbatim findings behind Christopher T Middendorf's 235 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site